Today: October 05, 2024
Today: October 05, 2024

Global data show women outliving men, But longevity gap varies

Global data show women outliving men, But longevity gap varies
June 03, 2024

The fascinating quest to become a healthy centenarian - living not just to the milestone age of 100 years, but doing so with a high quality of life - reveals surprising gender differences, according to longevity researcher Maddy Dychtwald. For women, the road to a long life expectancy with good health is surprisingly different from that of men. Even young adults in the current generation should start focusing on key factors that can extend both their lifespan and healthspan.

Read More

Related

Food|Health|Lifestyle

7 simple secrets to eating the Mediterranean way

7 simple secrets to eating the Mediterranean way

7 simple secrets to eating the Mediterranean way
Business|Health|Science

Pfizer's Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts say

Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed up trials of new

Pfizer's Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts say
Business|Europe|Health|News

EU regulator recommends suspension of Pfizer's sickle cell disease treatment

The European Medicines Agency (EMA) recommended suspending the marketing authorization for Pfizer's sickle cell disease drug Oxbryta on Thursday.

EU regulator recommends suspension of Pfizer's sickle cell disease treatment
Health|News|Science

US health authorities need to play a larger role in cannabis policy, a new report says

A scientific panel is calling for a public health approach to marijuana that’s a big departure from “Just Say No.” The report was released Thursday by the National Academies of Sciences, Engineering and Medicine

US health authorities need to play a larger role in cannabis policy, a new report says
Business|Finance|Health|News|Stock Markets

Healthcare firm Guardian Pharmacy valued at about $880 million in lukewarm NYSE debut

Guardian Pharmacy's shares rose 3.3% in their NYSE debut on Thursday, giving the healthcare firm a market valuation of about $880 million, as investors remained selective about new listings

Healthcare firm Guardian Pharmacy valued at about $880 million in lukewarm NYSE debut
Share This

Popular

Health|MidEast|News|World

Israel-Hamas war latest: Israel carries out attacks in Beirut on Hezbollah targets

Israel-Hamas war latest: Israel carries out attacks in Beirut on Hezbollah targets
Health|News|Science

How to make sure your generator doesn't kill you

How to make sure your generator doesn't kill you
Education|Health|Lifestyle|News|Science

Suicide attempts increased among transgender teens when states passed anti-trans laws, study says

Suicide attempts increased among transgender teens when states passed anti-trans laws, study says
Health|News

Free Covid-19 tests are available again. Here’s how to get them

Free Covid-19 tests are available again. Here’s how to get them